Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07133412

An Evaluation of the Neuromuscular Junction in Neonates Using the TetraGraph

An Evaluation of the Neuromuscular Junction in Infants Using Train-of-four Monitoring With the TetraGraph™ Neuromuscular Transmission Monitor

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Joseph D. Tobias · Academic / Other
Sex
All
Age
28 Days – 25 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to use electromyography-based train-of-four monitoring (TetraGraph™ Neuromuscular Transmission Monitor) as a means of evaluating differences in neuromuscular transmission between infants ≤ 3 months of age and adolescent and older patients (≥ 12 years of age).

Conditions

Interventions

TypeNameDescription
DEVICETetraGraphTetraGraph is a unique, EMG-based portable device for quantitative (objective) monitoring of neuromuscular function. It is a precise and easy to use tool for monitoring depth of block, ensuring adequate recovery of muscle function, and aiding the clinician to reduce the incidence of residual block.

Timeline

Start date
2026-07-01
Primary completion
2027-12-01
Completion
2027-12-01
First posted
2025-08-21
Last updated
2026-04-03

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07133412. Inclusion in this directory is not an endorsement.

An Evaluation of the Neuromuscular Junction in Neonates Using the TetraGraph (NCT07133412) · Clinical Trials Directory